• I. E. Valverde, F. Lecaille, G. Lalmanach, V. Aucagne & A. F. Delmas. A biologically active bis-triazolo analogue of cystatin A through successive peptidomimetic alkyne/azide ligations. (2012) Angew. Chem. Int. Ed. 51, 718-722. 
 
  • A. Rieux, S. Gras, F. Lecaille, A. Niepceron, A. Silvestre, F. I. Bussière, G. Lalmanach & F. Brossier. Eimeripain, a cysteine cathepsin B-like protease, expressed throughout sporulation of the apicomplexan parasite Eimeria Tenella. (2012) PLoS ONE 7, e31914.
 
  • V. Laurent-Matha, P. Huesgen, O. Masson, D. Derocq, C. Prébois, M. Gary-Bobo, F. Lecaille, B. Rebière, G. Meurice, C. Oréar, R. E. Hollingsworth, M. Abrahamson, G. Lalmanach, C. Overall & E. Liaudet-Coopman. Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment. (2012) FASEB J 12, 5172-5181.
 
  • J. Sage, E. Noblesse, C. Nizard, T. Sasaki, S. Schnebert, E. Perrier, R. Kurfurst, D. Brömme, G. Lalmanach & F. Lecaille. Cleavage of nidogen-1 by cathepsin S impairs its binding properties to basement membrane partners. (2012) PLoS ONE 7, e43494.
 
  • Wysocka M, Lesner A, Gruba N, Korkmaz B, Gauthier F, Kitamatsu M, Legowska, A, Rolka, K. (2012). The three wavelength substrate system of neutrophil serine proteinases. Anal. Chem. 84(16):7241-8.
 
  • Derache C, Epinette C, Roussel A, Gabant G, Cadene M, Korkmaz B, Gauthier F, Kellenberger C. (2012). Crystal structure of Greglin, a novel non-classical Kazal inhibitor, in complex with subtilisin. FEBS J. 279, 4466-78.
 
  • Korkmaz B, Attucci S, Epinette C, Pitois E, Jourdan ML, Juliano L, Gauthier F. (2012). Measurement of neutrophil elastase, proteinase 3, and cathepsin G activities using intramolecularly quenched fluorogenic substrates. Methods Mol Biol. 84, 125-38.
     
  • Epinette C, Croix C, Jaquillard L, Jégot G, Marchand-Adam S, Kellenberger C, Lalmanach G, Cadène M, Viaud-Massuard MC, Gauthier F and Korkmaz B. (2012). A reversible azapeptide inhibitor of human proteinase 3 derived from one of its high affinity FRET substrates. Biochem. Pharmacol. 83, 788–796.
 
  • S. Thenin, E. Roch, T. Samleerat, T. Moreau, A. Chaillon, A. Moreau, F. Barin and M. Braibant (2012) Naturally Occuring Substitutions Of Conserved Residues In Hiv-1 Variants Of Different Clades Are Involved In Pg9 And Pg16 Resistance To Neutralization. J. Gen. Virol. 93, 1495-505.
 
  • A. Tanga, A. Saidi, M.L. Jourdan, S. Dallet, M.L. Zani and T. Moreau (2012) Protection Of Lung Epithelial Cells From Protease-Mediated Injury By Trappin-2 A62l, An Engineered Inhibitor Of Neutrophil Serine Proteases. Biochem. Pharmacol. 83, 1663-73.
 
  • H. Mameri, S. Denery-Papini, M. Pietri, O. Tranquet, C. Larre, M. Drouet, E. Paty, A.M. Jonathan, E. Beaudouin, D.A. Moneret-Vautrin, T. Moreau, P. Briozzo and J.C. Gaudin (2012). Molecular And Immunological Characterization Of Wheat Serpin. Mol. Nutr. Food Res. 56, 1874-83. 
 
  • Jouan Y, Venel Y, Lioger B, du Sorbier CM, Gaucher L, Marchand-Adam S, Diot P and Diot E. (2012) Tracheal involvement in ulcerative colitis: clinical presentation and potential interest of 2-deoxy-2[(18)F]fluoro-D-glucose positron emission tomography ((18)F-FDG PET) for the management. Ann Nucl Med. 10, 830-834. 
 
  • Crestani B, Marchand-Adam S, Quesnel C, Plantier L, Borensztajn K, Marchal J, Mailleux A, Soler P, Dehoux M.  (2012) Hepatocyte growth factor and lung fibrosis Proc. Am. Thorac. Soc. 9, 158-163.